HFEA allows PGD and tissue typing
The UK's Human Fertilisation and Embryology Authority (HFEA) announced last week that it would, in principle, allow the use of HLA (Human Leukocyte Antigen) typing, more commonly known as 'tissue typing', in conjunction with preimplantation genetic diagnosis (PGD) for serious disease. The HFEA will consider each application to use the...